Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Pannecouque

Showing results (31-40 of 426) with videos related to

Pageof 43
Sort By:
Bioorganic & Medicinal Chemistry|July 20, 2010
Anti-HIV and antiplasmodial activity of original flavonoid derivativesGilles Casano, Aurélien Dumètre, Christophe Pannecouque, et al.
Archiv Der Pharmazie|September 5, 2002
Anti-HIV activity of thiosemicarbazone and semicarbazone derivatives of (+/-)-3-menthoneVibha Mishra, S N Pandeya, Christophe Pannecouque, et al.
Journal of Medicinal Chemistry|May 28, 2004
Design, synthesis, anti-HIV activities, and metabolic stabilities of alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitorsMaximilian A Silvestri, Muthukaman Nagarajan, Erik De Clercq, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2019
Polyfluoroaromatic stavudine (d4T) ProTides exhibit enhanced anti-HIV activitySahar Kandil, Christophe Pannecouque, Fiona M Chapman, et al.
Bioorganic Chemistry|April 26, 2020
Privileged scaffold inspired design of novel oxime-biphenyl-DAPYs in treatment of HIV-1Yang Yang, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry|April 14, 2021
Hydrophobic Pocket Occupation Design of Difluoro-Biphenyl-Diarylpyrimidines as Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors: from <i>N</i>-Alkylation to Methyl Hopping on the Pyrimidine RingLi Ding, Christophe Pannecouque, Erik De Clercq, et al.
Chemical & Pharmaceutical Bulletin|July 5, 2003
Nonnucleoside HIV-1 reverse transcriptase inhibitors: Part I. Synthesis and structure-activity relationship of 1-alkoxymethyl-5-alkyl-6-naphthylmethyl uracils as HEPT analoguesGe Meng, Fen-Er Chen, Erik De Clercq, et al.
Journal of Medicinal Chemistry|July 1, 2021
Improving Druggability of Novel Diarylpyrimidine NNRTIs by a Fragment-Based Replacement Strategy: From Biphenyl-DAPYs to Heteroaromatic-Biphenyl-DAPYsLi Ding, Christophe Pannecouque, Erik De Clercq, et al.
Chemistry & Biodiversity|January 22, 2008
Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analoguesYueping Wang, Fen-Er Chen, Jan Balzarini, et al.
Journal of Medicinal Chemistry|March 30, 2023
Fragment Hopping-Based Design of Novel Biphenyl-DAPY Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Improved Anti-Resistance EfficacyYa-Li Sang, Christophe Pannecouque, Erik De Clercq, et al.
Pageof 43

Showing results (31-40 of 426) with videos related to

Sort By:
Pageof 43
Bioorganic & Medicinal Chemistry|July 20, 2010
Anti-HIV and antiplasmodial activity of original flavonoid derivativesGilles Casano, Aurélien Dumètre, Christophe Pannecouque, et al.
Archiv Der Pharmazie|September 5, 2002
Anti-HIV activity of thiosemicarbazone and semicarbazone derivatives of (+/-)-3-menthoneVibha Mishra, S N Pandeya, Christophe Pannecouque, et al.
Journal of Medicinal Chemistry|May 28, 2004
Design, synthesis, anti-HIV activities, and metabolic stabilities of alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitorsMaximilian A Silvestri, Muthukaman Nagarajan, Erik De Clercq, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2019
Polyfluoroaromatic stavudine (d4T) ProTides exhibit enhanced anti-HIV activitySahar Kandil, Christophe Pannecouque, Fiona M Chapman, et al.
Bioorganic Chemistry|April 26, 2020
Privileged scaffold inspired design of novel oxime-biphenyl-DAPYs in treatment of HIV-1Yang Yang, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry|April 14, 2021
Hydrophobic Pocket Occupation Design of Difluoro-Biphenyl-Diarylpyrimidines as Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors: from <i>N</i>-Alkylation to Methyl Hopping on the Pyrimidine RingLi Ding, Christophe Pannecouque, Erik De Clercq, et al.
Chemical & Pharmaceutical Bulletin|July 5, 2003
Nonnucleoside HIV-1 reverse transcriptase inhibitors: Part I. Synthesis and structure-activity relationship of 1-alkoxymethyl-5-alkyl-6-naphthylmethyl uracils as HEPT analoguesGe Meng, Fen-Er Chen, Erik De Clercq, et al.
Journal of Medicinal Chemistry|July 1, 2021
Improving Druggability of Novel Diarylpyrimidine NNRTIs by a Fragment-Based Replacement Strategy: From Biphenyl-DAPYs to Heteroaromatic-Biphenyl-DAPYsLi Ding, Christophe Pannecouque, Erik De Clercq, et al.
Chemistry & Biodiversity|January 22, 2008
Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analoguesYueping Wang, Fen-Er Chen, Jan Balzarini, et al.
Journal of Medicinal Chemistry|March 30, 2023
Fragment Hopping-Based Design of Novel Biphenyl-DAPY Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Improved Anti-Resistance EfficacyYa-Li Sang, Christophe Pannecouque, Erik De Clercq, et al.
Pageof 43